{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:37:42Z","timestamp":1761183462850,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001863","name":"New Energy and Industrial Technology Development Organization (NEDO), Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and development, AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["26293032","26293032"],"award-info":[{"award-number":["26293032","26293032"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.dmpk.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T03:08:49Z","timestamp":1469934529000},"page":"395-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in\u00a0vitro experiments"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-8281","authenticated-orcid":false,"given":"Kayoko","family":"Kanamitsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Suhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2016.07.003_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmpk.2016.07.003_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-3659(99)00036-X","article-title":"Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain","volume":"62","author":"Sugiyama","year":"1999","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.dmpk.2016.07.003_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/dmd.108.022814","article-title":"Receptor occupancy and brain free fraction","volume":"37","author":"Watson","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2016.07.003_bib4","first-page":"81","article-title":"Positron emission tomography studies on D2 dopamine receptor occupancy and antipsychotic drug plasma levels in man","volume":"10","author":"Nyberg","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007691-200408000-00004","article-title":"Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response","volume":"26","author":"Yasui-Furukori","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dmpk.2016.07.003_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine: an atypical antipsychotic","volume":"40","author":"DeVane","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2016.07.003_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00213-010-1783-1","article-title":"Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects","volume":"209","author":"Arakawa","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.dmpk.2016.07.003_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244923","article-title":"Seroquel: biochemical profile of a potential atypical antipsychotic","volume":"112","author":"Saller","year":"1993","journal-title":"Psychopharmacol Berl"},{"key":"10.1016\/j.dmpk.2016.07.003_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020050047","article-title":"In\u00a0vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018 and its metabolite, in rat brain","volume":"105","author":"Takahashi","year":"1998","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.dmpk.2016.07.003_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejphar.2005.11.051","article-title":"Changes in pH differently affect the binding properties of histamine H1 receptor antagonists","volume":"530","author":"Gillard","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A\u00a0pharmacokinetic analysis program (multi) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J\u00a0Pharmacobiodyn"},{"key":"10.1016\/j.dmpk.2016.07.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)15016-5","article-title":"The kinetics of competitive radioligand binding predicted by the law of mass action","volume":"25","author":"Motulsky","year":"1984","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jps.21405","article-title":"Ionization-specific prediction of blood-brain permeability","volume":"98","author":"Lanevskij","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.dmpk.2016.07.003_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in\u00a0vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.dmpk.2016.07.003_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.dmpk.2016.07.003_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2125.2005.02507.x","article-title":"Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics","volume":"61","author":"Grimm","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.pnpbp.2006.02.012","article-title":"Effect of carbamazepine on the single oral dose pharmacokinetics of perospirone and its active metabolite","volume":"30","author":"Masui","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.dmpk.2016.07.003_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ftd.0000185767.59749.bb","article-title":"Effects of itraconazole and tandospirone on the pharmacokinetics of perospirone","volume":"28","author":"Masui","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dmpk.2016.07.003_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2011.05.050","article-title":"Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors","volume":"666","author":"Tadori","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF03190868","article-title":"In\u00a0vitro metabolism of perospirone in rat, monkey, and human liver microsomes","volume":"28","author":"Mizuno","year":"2003","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.dmpk.2016.07.003_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2005.02.051","article-title":"Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic","volume":"515","author":"Tadori","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2009.02.007","article-title":"Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors","volume":"607","author":"Tadori","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.110.035998","article-title":"Hammarlund-Udenaes, et al., Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods","volume":"39","author":"Frid\u00e9n","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2016.07.003_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00228-008-0487-5","article-title":"Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells","volume":"64","author":"Zhou","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-3565(25)10423-0","article-title":"Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1)","volume":"263","author":"Tanigawara","year":"1992","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmpk.2016.07.003_bib26","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.dmpk.2016.07.003_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1017\/S1461145711000514","article-title":"Comparison of D2 dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects","volume":"14","author":"Nord","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.dmpk.2016.07.003_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in\u00a0vitro and in\u00a0vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.dmpk.2016.07.003_bib29","unstructured":"http:\/\/kidbdev.med.unc.edu\/databases\/pdsp.php."},{"key":"10.1016\/j.dmpk.2016.07.003_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.dmpk.2016.07.003_bib31","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00213-015-4002-2","article-title":"Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers","volume":"232","author":"Sato","year":"2015","journal-title":"Psychopharmacol Berl"},{"key":"10.1016\/j.dmpk.2016.07.003_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4088\/JCP.08m04307yel","article-title":"Positron emission tomography measurement of dopamine D2 receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia","volume":"71","author":"Arakawa","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.dmpk.2016.07.003_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clpt.2005.01.022","article-title":"Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography","volume":"77","author":"Sasongko","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2016.07.003_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004647-199902000-00012","article-title":"Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in\u00a0vivo: a test-retest analysis","volume":"19","author":"Hietala","year":"1999","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.dmpk.2016.07.003_bib35","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/nbm.1693","article-title":"Measurement of absolute arterial cerebral blood volume in human brain without using a contrast agent","volume":"24","author":"Hua","year":"2011","journal-title":"NMR Biomed"},{"key":"10.1016\/j.dmpk.2016.07.003_bib36","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1124\/dmd.107.015222","article-title":"In\u00a0vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids","volume":"35","author":"Frid\u00e9n","year":"2007","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436716300441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436716300441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:53:07Z","timestamp":1761162787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436716300441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1347436716300441"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2016.07.003","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in\u00a0vitro experiments","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}